Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Feb 2026 and May 2026.
- Largest single sale: $1.0M (13,400 shares) of BridgeBio Pharma, Inc. on Feb 17, 2026. Filing
- Last sale before this period: Aug 21, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | President and CFO | Jul 29, 2024 | Aug 18, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 16, 2026, BridgeBio Pharma, Inc.: 22,781 shares withheld by the company for taxes. 1 filing: 1
- May 18, 2026, BridgeBio Pharma, Inc.: sold 13,651 shares for $888K, under a disclosed plan. 1 filing: 1
- May 16, 2026, BridgeBio Pharma, Inc.: 22,781 shares withheld by the company for taxes. 1 filing: 1
- Mar 18, 2026, BridgeBio Pharma, Inc.: 59,041 shares granted. 1 filing: 1
- Feb 17, 2026, BridgeBio Pharma, Inc.: sold 13,600 shares for $1.0M, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.